Zhonghua Wai Ke Za Zhi. 2018 Apr 1;56(4):241-258. doi: 10.3760/cma.j.issn.0529-5815.2018.E001.
Colorectal cancer is one of the most common malignant tumors in China. In 2012 one million thirty six thousand cases of colorectal cancer were diagnosed all over the world, two hundred fifty three thousand cases were diagnosed in China (accounted for 18.6%). China has the largest number of new cases of colorectal cancer in the world. Colorectal cancer has becoming a serious threat of Chinese residents' health. In 2010, the National Ministry of Health organized colorectal cancer expertise of the Chinese Medical Association to write the "Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer" (2010edition), and publish it publicly. In recent years, the National Health and Family Planning Commission has organized experts to revised the protocol 2 times: the first time in 2015, the second time in 2017. The revised part of "Chinese Protocol of Diagnosis and Treatment of Colorectal Cancer" (2017 edition) involves new progress in the field of imaging examination, pathological evaluation, surgery, chemotherpy and radiotherapy. The 2017 edition of the protocol not only referred to the contents of the international guidelines, but also combined with the specific national conditions and clinical practice in China, and also included many evidence-based clinical data in China recently. The 2017 edition of the protocol would further promote the standardization of diagnosis and treatment of colorectal cancer in China, improve the survival and prognosis of patients, and benefit millions of patients with colorectal cancer and their families.
结直肠癌是中国最常见的恶性肿瘤之一。2012年，全球共诊断出103.6万例结直肠癌病例，其中中国有25.3万例（占18.6%）。中国是世界上结直肠癌新发病例数最多的国家。结直肠癌已成为威胁中国居民健康的严重疾病。2010年，国家卫生部组织中华医学会结直肠癌专家编写了《中国结直肠癌诊疗规范（2010年版）》并公开发布。近年来，国家卫生和计划生育委员会组织专家对该规范进行了2次修订：第一次在2015年，第二次在2017年。《中国结直肠癌诊疗规范（2017年版）》修订部分涉及影像检查、病理评估、手术、化疗和放疗等领域的新进展。2017年版规范不仅参考了国际指南的内容，还结合了中国的具体国情和临床实践，纳入了国内近期许多循证医学临床数据。2017年版规范将进一步推动中国结直肠癌诊疗的规范化，提高患者的生存率和预后，造福数百万结直肠癌患者及其家庭。
